178 GASTRO-ENTEROLOGY Zdrav Vestn | March – April 2021 | Volume 90 | https://doi.org/10.6016/ZdravVestn.3005 Faculty of Medicine, University of Maribor, Maribor, Slovenia Correspondence/ Korespondenca: Maja Šikić Pogačar, e: maja_sikic@yahoo.com.au Key words: diet; gut microbiota; polyphenols; probiotics; prebiotics Ključne besede: prehrana; črevesna mikrobiota; polifenoli; probiotiki; prebiotiki Prispelo: 12. 11. 2019 Sprejeto: 27. 9. 2020 eng slo element en article-lang 10.6016/ZdravVestn.3005 doi 12.11.2019 date-received 27.9.2020 date-accepted Gastro-enterology Gastroenterologija discipline Professional article Strokovni članek article-type The influence of dietary compounds on gut microbiota Vpliv prehrane na črevesno mikrobioto article-title The influence of dietary compounds on gut microbiota Vpliv prehrane na črevesno mikrobioto alt-title diet, gut microbiota, polyphenols, probiotics, prebiotics prehrana, črevesna mikrobiota, polifenoli, probio- tiki, prebiotiki kwd-group The authors declare that there are no conflicts of interest present. Avtorji so izjavili, da ne obstajajo nobeni konkurenčni interesi. conflict year volume first month last month first page last page 2021 90 3 4 178 192 name surname aff email Maja Šikić Pogačar 1 maja_sikic@yahoo.com.au name surname aff Dušanka Mičetić Turk 1 eng slo aff-id Faculty of Medicine, University of Maribor, Maribor, Slovenia Medicinska fakulteta, Univerza v Mariboru, Maribor, Slovenija 1 The influence of dietary compounds on gut microbiota Vpliv prehrane na črevesno mikrobioto Maja Šikić Pogačar, Dušanka Mičetić Turk Abstract The gut microbiota is a complex community composed of trillions of microbes that adapts to its host over the lifetime. Recently, the advances of the methods of high-throughput sequencing have allowed the identification of microbial species in a stool sample, and mass spectrometry identification of their metabolites, both of which together have enabled much of the relevant research in the field. It has became evident that gut microbiota plays an important role in human health and influences the risk of developing many chronic diseases, including obesity, inflam- matory bowel disease, type 2 diabetes, cardiovascular disease, and cancer. The diverse ecosys- tem of the gut includes bacteria, viruses, phages, yeasts, archaea, fungi and protozoa. They are responsible for the production of bioactive metabolites, regulation of immune function, energy homeostasis and protection against pathogens. The mentioned functions are dependent on the diversity and abundance of the microbiota which is the reflection of the dietary habits and ge- netics of the host among other factors. As such, gut microbiota has significant interindividual variations. Diet and lifestyle changes present important determinants in microbiota shaping. The use of antibiotics, different sanitation measures, consumption of processed food and different diets are also reflected in the shifts of gut microbiota composition. Some of the dramatic dietary alterations can cause changes in gut microbiota composition already within 24 h and some of these changes may be difficult to reverse. Through modulation of gut microbiota composition, diet could offer a potential to manage the risk of developing disease and at the same time im- proving the quality of life and longevity. In this review we look at the role of diet, and specific dietary components, namely carbohydrates, proteins, fats and polyphenols on gut microbiota composition. Izvleček Črevesna mikrobiota je kompleksna skupnost, sestavljena iz milijarde mikroorganizmov, ki živijo z gostiteljem in se mu vse življenje prilagajajo. V zadnjem času je napredek metod sekvencioni- ranja DNK visoke zmogljivosti omogočil identificiranje posameznih vrst bakterij v vzorcu blata, metoda masne spektrometrije identifikacijo njihovih presnovkov, oboje pa veliko raziskav na tem področju. Postalo je očitno, da igra črevesna mikrobiota pomembno vlogo pri zdravju ljudi in vpliva na tveganje za razvoj številnih kroničnih bolezni, vključno z debelostjo, vnetno črevesno boleznijo, diabetesom tipa 2, srčno-žilnimi boleznimi in rakom. Raznolik ekosistem v črevesju zajema bakterije, viruse, fage, kvasovke, arheje, glive in protozoje. Odgovorni so za tvorbo bio- aktivnih presnovkov, uravnavanje imunskega delovanja, energijsko homeostazo in zaščito pred patogenimi mikroorganizmi. Te funkcije so odvisne od raznolikosti in številčnosti mikrobiote, ki pa je med drugim tudi odraz prehranjevalnih navad in genetike gostitelja. Črevesna mikrobio- ta tako kaže pomembne razlike med posamezniki. Prehrana in življenjski slog sta pomembna dejavnika pri oblikovanju mikrobiote. Uporaba antibiotikov, različni sanitarni ukrepi, uživanje predelane hrane in različne diete se kažejo tudi v spremembah sestave mikrobiote črevesja. Ne- katere dramatične prehranske spremembe lahko povzročijo hitre spremembe v sestavi črevesne Slovenian Medical Journal 179 PROFESSIONAL ARTICLE The influence of dietary compounds on gut microbiota 1 Introduction Scientists have been interested in gut microbiota for years but the inabil- ity to isolate and culture anaerobic mi- croorganisms in vitro was holding back much of the relevant research in that field. With advances in the methods of high-throughput sequencing and mass-spectrometry in the last 15 years, it has finally become possible to identi- fy microbial species and their function in a stool sample bypassing the tradi- tional culture-dependent techniques for the isolation, identification and char- acterization of microorganisms (1,2). Nowadays, sequencing platforms allow analysis of all the genomes within an ecosystem (i.e. shotgun metagenomics), or a description of the taxa within a giv- en community by sequencing conserved marker genes (i.e. 16S rRNA gene). On the other hand, mass spectrometry al- lowed detection of microbial derived products, including metabolites and proteins, which regulate numerous bio- logical pathways and also facilitate inter- species interactions within the human host (1,3,4). Gut microbiota consists of a diverse microbial community that encompasses 1014 microorganisms, including bacteria, mikrobiote, in sicer že v 24 urah, nekatere od teh sprememb pa je težko povrniti v prvotno sesta- vo. Z moduliranjem sestave črevesne mikrobiote ponuja prehrana orodje za zmanjšanje tveganja za razvoj bolezni, hkrati pa izboljša kakovost življenja in vpliva na podaljšanje življenjske dobe. Namen preglednega članka je predstaviti dosedanje znanje o vplivu prehrane in posameznih se- stavin hrane, in sicer ogljikovih hidratov, beljakovin, maščob in polifenolov na sestavo črevesne mikrobiote. Cite as/Citirajte kot: Šikić Pogačar M, Mičetić Turk D. The influence of dietary compounds on gut microbiota. Zdrav Vestn. 2021;90(3–4):178–92. DOI: https://doi.org/10.6016/ZdravVestn.3005 Copyright (c) 2021 Slovenian Medical Journal. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. viruses, phages, yeasts, archaea, fungi and protozoa, all of which are commen- sal and play a role in the complex interac- tions within the human gastrointestinal (GIT) tract (2,5). Within the host, it also varies taxonomically and functionally according to the intestine anatomical re- gions (3). The mutual synergy between the gut microbiota and its host is often being referred to as a »superorganism« or a host extra organ (6). Merely in the colon, the density of bacterial cells has been estimated to be 1012 colony forming units (CFU) per gram content (5). The dominant phy- la in GIT are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fuso- bacteria, and Verrucomicrobia. Howev- er, gram positive Firmicutes and gram negative Bacteroidetes represent 90% of gut microbiota (3,5). A useful meth- od to stratify human gut microbiota is by separation of major taxa into clusters termed enterotypes. Three predominant variants (enterotypes) were identified by their enrichment in Bacteroides spp. (en- terotype 1), Prevotella spp. (enterotype 2) and Ruminococcus spp. (enterotype 3). Taken into account that enterotypes are defined depending on gut microbiota 180 GASTRO-ENTEROLOGY Zdrav Vestn | March – April 2021 | Volume 90 | https://doi.org/10.6016/ZdravVestn.3005 and gut microbiota changes rapidly in response to interventions, it would be easy to conclude that enterotypes are not a constant but rather a dynamic feature of individuals. However, even though enterotype is influenced by various fac- tors, the alternations of microbiota com- position during short intervals of time is insufficient to change the enterotype patterns due to the reversibility and rel- ative stability of gut microbiota. Conse- quently, enterotypes are associated with long-term dietary habits and remain rather stable throughout the adulthood while at the same time are unrelated to nationality or host characteristics such as body mass index, age or gender (7). The gut microbiota is important for the health of its host by performing many immune and metabolic functions (3). It is involved in the extraction, synthesis, and absorption of many nutrients and metabolites (including bile acids, vita- mins, amino acids) and it has a crucial role in preventing the colonization/in- vasion of pathogenic bacteria through the consumption of available nutrients, pH modification, competition for ad- hesion molecules and receptors, and/ or producing antimicrobial substances such as acids, bacteriocins, and others (3,5). The most important metabolic ac- tivity of gut microbiota in the large in- testine is the production of short chain fatty acids (SCFA) (acetate, propionate, and butyrate), mainly through fermen- tation of complex carbohydrates, such as oligosaccharides and resistant starch (6,8,9). Undigested proteins are also a substrate for SCFA production (9). Ab- sorbable SCFAs are considered anti-in- flammatory, an important modulators of gut health and immune function, in- testinal hormone production, and lipo- genesis (5,8,9). Furthermore, gut micro- biota has a critical role in regulating the development, homeostasis and function of innate and adaptive immune cells (3). The gut microbiota composition is formed in infancy, when individual is colonized by microorganisms from care- givers and the surrounding environment (10). The infant’s microbiota is rather instable with low diversity of bacteria and is strongly influenced by the mode of delivery, birth gestational age, type of feeding and the introduction of comple- mentary feeding. It changes through the exposure to a variety of environmental factors and eventually evolves toward a more stable adult-like composition by the age of 4 years (10-15). Furthermore, host genetics and dietary habits are re- sponsible for the huge variability in mi- crobiota composition and functionality among individuals. Likewise, body mass index, antibiotics, lifestyle, exercise fre- quency and ethnicity also influence the individual gut microbiota composition. Still, there is a similarity in microbiota composition among family members (3,11,16). Diet is an important determinant of microbiota composition by modulating the abundance of specific species and their functions. These could in turn in- duce changes in host physiology, includ- ing disease development and progres- sion (10-15). This review aims to provide the current knowledge of the role of diet (especially macronutrients) on gut mi- crobiota composition but also presents in short other factors. 2 Influence of diet on the gut microbiota In humans diet plays an important role in shaping the gut microbiota (17). It is the result of nutrient-induced selec- tive pressures placed on the gut microbi- ota, favouring bacterial species enriched 181 PROFESSIONAL ARTICLE The influence of dietary compounds on gut microbiota in the genes required for specific sub- strate metabolism (18). There were several fundamen- tal changes in the lifestyle of humans throughout the history, which had an impact on the co-evolution of microbi- al species associated with the host. The last radical change of dietary habits oc- curred less than 200 years ago with the Industrial Revolution and the shift away from local and seasonal foods. Gut mi- crobiota had to adapt to these profound changes in human diet. The modern diet is characterized by a high intake of ani- mal products and sugars, low intake of plant-based foods (fruits, vegetables and wholegrain cereals) and the use of addi- tives and preservatives (5). Even though the gut microbiota of a healthy adult is relatively stable, the changes in gut microbiota composition and/or abundance occur frequently due to dietary choices. Fruits and nuts, whole grain products, vegetables and le- gumes, meat and diary products, as well as food constituents, such as fat, protein, phytochemicals and fibres, impact gut microbiota composition in humans (17). In general, plant-based diets increase lu- minal fibre and complex carbohydrate content selecting for species enriched in carbohydrate-active enzymes. On the other hand, animal-based diets that are rich in fats and proteins and low in fi- bre increase luminal bile acid content, favouring bile acid-resistant microbes enriched with genes for bile acid metab- olism, such as bile salt hydrolases and sulfite reductase (18). Particularly significant changes in di- et (i.e. shifting from meat-based diets to strictly plant based) alter the composi- tion and function of gut microbiota fast, already within 24 h (5,19). Furthermore, if the diet becomes less diverse or defi- cient in some nutrients, some species of the gut microbiota are cut off causing the disruption between the host and its in- testinal microbiota. On contrary, a var- ied diet provides nutrients for a plethora of species of gut microbiota, which helps maintain homeostasis in the gut (11). 3 Carbohydrates and fibres It has been estimated that the quanti- ty of dietary carbohydrates that enter the colon each day is approximately 40 g and they belong to different categories such as: resistant starch, non-starch polysac- charides, oligosaccharides, as well as some di- and monosaccharides (4). The composition of gut microbiota is suscep- tible to both quality and quantity of in- gested carbohydrates, which serve as the main carbon and energy source for the gut microbiota (11). Upon degradation in the small intes- tine, starches and sugars (i.e. glucose, fructose, sucrose, and lactose) release glucose in the bloodstream and stimu- late insulin response (5). Fibres may be of particular importance as a non-di- gestible carbohydrates, representing a primary energy source for many gut microorganisms and stimulating the growth and activity of beneficial gut mi- croorganisms (17). Excess intake of carbohydrates as part of a Western diet high in refined grains, starch, and added sugar and low intake of dietary fibres (only 15 g/day) negatively impacts gut microbiota and is associat- ed with reduced diversity of gut micro- biota (i.e. bifidobacteria increased while Lactobacillus spp., Streptococcus spp., and Roseburia spp. decreased) (20). In addition, lower amounts of SCFAs were found in individuals consuming a West- ern diet (20). On the contrary, people in traditional societies, with a high fibre intake (50–120 g/day) harbour a much 182 GASTRO-ENTEROLOGY Zdrav Vestn | March – April 2021 | Volume 90 | https://doi.org/10.6016/ZdravVestn.3005 more diverse gut microbiota that is char- acterized by increasing good bacteria such as Bifidobacteria spp. and lactic ac- id bacteria and decreasing the counts of Bacteroides spp. (Figure 1). In addition, resistant starch and whole grain barley increased the abundance of Ruminococ- cus spp., E. rectale, and Roseburia spp. (4). Furthermore, as described in the study of Mills et al., people consuming high levels of simple sugars (glucose, fructose, and sucrose) in the form of date fruits had an increased abundance of bi- fidobacteria, with reduced Bacteroides spp. The addition of lactose to such di- et caused the same bacterial shifts while also decreasing Clostridia spp. Also, lac- tose supplementation increased the fecal concentration of SCFAs (4). Diet high in both sugar and fats result- ed in gut microbiota dysbiosis character- ised by a decrease in microbial diversity, an increase in clostridia and bacilli and a decrease in Lactobacillus spp. A noted increase in the Firmicutes:Bacteriodetes ratio was observed. Next, high sugar low fat diets caused an increase in two Pro- teobacteria members, namely Sutterella spp. and Bilophila spp. (4). Artificial sweeteners (saccharin, su- cralose, and aspartame) were originally Figure 1: Impact of carbohydrates and fiber on gut microbiota (According to Singh et al., 2017) (22). marketed as a health-conscious, no-cal- orie alternative to natural sugar. Howev- er, recent work by Suez et al. showed that artificial sweeteners can lead to glucose intolerance faster than glucose or su- crose. The effects produced by artificial sweeteners were thought to be mediated through alteration of gut microbiota (i.e. increased abundance of Bacteroides spp. and decreased Lactobacillus reuteri (21). 4 Dietary protein Dietary proteins have been reported to influence the composition of gut mi- crobiota since 1977 (6) and the advances of 16S rRNA sequencing enabled the as- sessment of the impact of dietary protein on the composition of gut microbiota in much more detail. Protein serves as an important nitro- gen source for the gut microbiota (22). The undigested nitrogenous compounds that are not absorbed in the small intes- tine are transferred to the large intestine where they are metabolized by the resi- dent gut microbiota. About 25 g of pro- tein, peptides and free amino acids enter the colon on daily basis (4). The initial step of bacterial protein catabolism in- cludes the extracellular hydrolysis of 183 PROFESSIONAL ARTICLE The influence of dietary compounds on gut microbiota proteins with hundreds of different bac- terial proteases. Both the amount and kind of metabolites are directly influ- enced by the intake amount and source of dietary protein (8). Bacteria involved in the protein me- tabolism in the small intestine include E.coli, Streptococcus spp., Succinivibrio dextrinosolvens, Mitsuokella spp., etc. (5,8). In the large intestine, the concen- tration of bacteria is much higher and the transit time longer than in the small intestine. Proteolytic activity in the large intestine has been associated with the genera Bacteroides, Propionibacterium, Streptococcus, Fusobacterium, Clostridi- um, and Lactobacillus (8,23). Gut micro- biota and residual pancreatic proteases digest proteins and peptides that escape digestion in the small intestine, resulting in the production of numerous micro- bial metabolites (i.e. SCFAs, ammonia, polyamines, hydrogen sulfide, phenolic, indolic compounds, etc.). Some of these microbial metabolites (i.e. hydrogen sul- fide, ammonia, and indolic compounds) have potentially negative effects on the host health. Others are bioactive mole- cules involved in various physiological processes in the host (8). Factors, such as protein source, con- centration and amino acid composition, can all affect gut microbiota and changes of gut microbiota composition can affect protein metabolism as well as the con- tent of microbial metabolites produced. Both of the latter are closely associated with the health of the host (8). The protein sources are mainly clas- sified as of animal or plant origin. Con- sumption of plant protein positively cor- relates with overall microbial diversity due to its lower digestibility when com- pared to animal protein (4,5,8). Consumption of soybean and pea- nut proteins positively modulates the beneficial bacterial composition in the GIT. A diet enriched with peanut pro- tein or whey altered gut microbiota di- versity with an increase of commensal Bifidobacterium spp. and Lactobacillus spp., and a reduction of Enterobacteria spp., Bacteroides fragilis and Clostridi- um perfringens (5,8). Increased num- bers of Bifidobacterium spp. contribute to generation of more microbial metab- olites, including SCFAs and lactic acid, resulting in a lower pH in GIT that in- hibits toxic metabolites, such as amine and benzpyrole. Intake of soybean can alter gut microbiota composition with increased communities of genera Esche- richia and Propionibacterium (8). Compared to plant proteins, animal proteins are highly digestible, however, animal-based diets are often also high in fat in addition to protein (5). Increased numbers of bile-tolerant anaerobes (genera Bacteroides, Alistipes and Bilo- phila) were found in the microbiota of individuals consuming animal-based proteins (5). Casein has been shown to increase the counts of lactobacilli and bifidobacteria, while on the other hand decreasing the counts of Staphylococcus spp., coliforms, and Streptococcus spp. in GIT (8). Moreover, animal protein is characterized by a reduction of SCFA and an increase of both gut pH and am- monia concentration (8). The individuals consuming a diet rich in beef had high levels of Bacteroi- des spp. and Clostridium spp. and at the same time low levels in Bifidobacterium adolescentis when compared to their vegetarian counterparts (5). When protein intake is increased, the amount of undigested protein in the large intestine increases. Consequent- ly, more substrate for gut microbiota is available. High concentration of protein increased the abundance of bile-tolerant 184 GASTRO-ENTEROLOGY Zdrav Vestn | March – April 2021 | Volume 90 | https://doi.org/10.6016/ZdravVestn.3005 microorganisms (genera Alistipes, Bilo- phila and Bacteroides) while decreasing the levels of Firmicutes that metabolize plant polysaccharides (genera Roseburia, Eubacterium rectale and Ruminococcus) (24). In addition, high-protein diet led to a decrease in abundance of genera Ru- minococcus and Akkermansia (4). High concentrations of protein intake can result in increases in counts of poten- tial pathogens due to disruption in the homeostasis of the gut micro-ecosystem with reductions of beneficial microbes (8). Similarly, when the concentration of protein in the diet is too low to meet the basic requirement of the host, it can increase the abundance of potential pathogens (i.e. coliforms) and decrease the population of beneficial bacteria in the gut (i.e. lactobacilli). Furthermore, lower concentrations of dietary protein decreased butyrate-producing bacteria including lactobacilli and bifidobacteria, which have a protective, anti-inflamma- tory activity against carcinogenesis and intestinal disorders (25,26). 5 Fats Dietary fat vary greatly with respect to its structure and composition of fatty ac- ids. The latter can be short (i.e. 6 carbon atoms) or long (up to 24 carbon atoms), and can also contain double bonds (4). Besides the amount, fatty acid composi- tion of the fat source is important when analyzing its impact on gut microbiota composition and function. The typical Western diet is both high in saturated and trans fats while low in mono- and polyunsaturated fats (5). Animal studies have shown that a high fat diet leads to the establishment of mi- crobiota low in Lactobacillus intestinalis and high in Clostridiales, Bacteroidales, and Enterobacteriales (27). In addition, lard-fed mice showed increased num- bers of Bacteroides spp. and Bilophila spp. and reduced levels of Desulfovibrio spp., while those fed with fish oil had in- creased lactic acid bacteria (Lactobacil- lus spp. and Streptococcus spp.), genera Verrucomicrobia (A. muciniphila), and Actinobacteria (Bifidobacterium spp. and Adlercreutzia spp.) and mice fed with a diet rich in milk fat showed increased levels of Bilophila wadsworthia (27). In humans, rapid and profound changes of gut microbiota composition caused by consumption of high-fat diets consisting solely of animal-based foods (i.e. meat and cheese) were observed in the study of David et al. The particu- lar study showed that humans given an animal-based diet, consisting of 69.5% kcal from fat, 30.1% kcal from protein and nearly 0 g of fiber, altered the com- position of gut microbiota within 48 hours of diet initiation (28). The growth of bile-tolerant and pathogenic hydro- gen-sulfide producing bacteria such as Bilophila wadsworthia was observed in the same study (28). A recent interven- tional study has shown that a high-fat diet in healthy adults is associated with increased levels of Alistipes spp. and Bacteroides spp. and a decrease in Fae- calibacterium spp. (29). Consumption of a low fat diet leads to the over-abun- dance of bifidobacteria and a reduction of fasting glucose and total cholesterol, while a high saturated fat diet increased the relative proportion of Faecalibacteri- um prausnitzii (30). High-fat diets also enrich the abundance of Bacteroides spp. as well as of total anaerobic microorgan- isms (Figure 2) (30,31). When monounsaturated fat intake was high, no shifts in relative abun- dance of any bacterial genera were ob- served. However, such diet resulted in a reduced total bacterial load and plasma Figure 2: Impact of protein and fat on gut microbiota (According to Singh et al., 2017) (22). 185 PROFESSIONAL ARTICLE The influence of dietary compounds on gut microbiota lard-fed mice showed increased num- bers of Bacteroides spp. and Bilophila spp. and reduced levels of Desulfovibrio spp., while those fed with fish oil had in- creased lactic acid bacteria (Lactobacil- lus spp. and Streptococcus spp.), genera Verrucomicrobia (A. muciniphila), and Actinobacteria (Bifidobacterium spp. and Adlercreutzia spp.) and mice fed with a diet rich in milk fat showed increased levels of Bilophila wadsworthia (27). In humans, rapid and profound changes of gut microbiota composition caused by consumption of high-fat diets consisting solely of animal-based foods (i.e. meat and cheese) were observed in the study of David et al. The particu- lar study showed that humans given an animal-based diet, consisting of 69.5% kcal from fat, 30.1% kcal from protein and nearly 0 g of fiber, altered the com- position of gut microbiota within 48 hours of diet initiation (28). The growth of bile-tolerant and pathogenic hydro- gen-sulfide producing bacteria such as Bilophila wadsworthia was observed in the same study (28). A recent interven- tional study has shown that a high-fat diet in healthy adults is associated with increased levels of Alistipes spp. and Bacteroides spp. and a decrease in Fae- calibacterium spp. (29). Consumption of a low fat diet leads to the over-abun- dance of bifidobacteria and a reduction of fasting glucose and total cholesterol, while a high saturated fat diet increased the relative proportion of Faecalibacteri- um prausnitzii (30). High-fat diets also enrich the abundance of Bacteroides spp. as well as of total anaerobic microorgan- isms (Figure 2) (30,31). When monounsaturated fat intake was high, no shifts in relative abun- dance of any bacterial genera were ob- served. However, such diet resulted in a reduced total bacterial load and plasma Figure 2: Impact of protein and fat on gut microbiota (According to Singh et al., 2017) (22). total- and LDL-cholesterol (30). Like- wise, consumption of salmon (that is high in mono- and polyunsaturated fats) was not noted to alter faecal microbi- ota composition in the study of Urwin et al. (32). A study comparing saturated fat (lard) to long-chain polyunsaturated fatty acids (PUFA, from fish oil) detect- ed significant differences in the gut mi- crobiota composition and host adiposity (33). High-saturated fat, such as palm oil, reduced microbial diversity and in- creased Firmicutes:Bacteroidetes ratio (4). In the study of Martinez et al., diet rich in fish oil prevented against nega- tive shifts in gut microbes and resulted in a decrease in host obesity-associated inflammation (33). Next, Huang et al. showed that a diet rich in omega-6 PUFA (from safflower oil) resulted in altered gut microbiota composition compared with diets rich in saturated milk fat or lard (34). Prieto et al. found that a diet enriched with extra virgin olive oil had a different effect on the gut microbiota in comparison with an enriched butter diet (35). In people taking omega-3 PU- FA supplementation a decrease in Fae- calibacterium spp., often associated with an increase in the Bacteroidetes spp. and butyrate-producing bacteria belonging to the Lachnospiraceae family, has been observed (36). 6 Gut microbiota and polyphenols Dietary polyphenols include flavo- nols, flavones, anthocyanins, proantho- cyanidins, phenolic acids, catechins, etc. Most of them were studied for their an- tioxidant properties and as inhibitors of pathogenic microorganism growth (5). Polyphenol intake is affected by several factors including geographical area, the population characteristics (i.e. age, gen- der and socio-cultural factors) and most importantly their dietary habits. The intake of total polyphenols is compa- rable in European countries and North and South America (about 900 mg/day and 800 mg/day respectively). Howev- er, within Europe, the intake of poly- phenols varies greatly (i.e. Poland and France have both intake of above 1000 mg/day, while Italy has around 650 mg/ day and Spain about 300 mg/day) (37). A majority of polyphenols enter the large intestine without being absorbed in the small intestine (38,49). There the polyphenols are degraded by the resi- dent microbiota, including Bacteroides 186 GASTRO-ENTEROLOGY Zdrav Vestn | March – April 2021 | Volume 90 | https://doi.org/10.6016/ZdravVestn.3005 diastasonis, Bacteroides ovatus, Bacteroi- des uniformis, Enterococcus casseliflavus, Eubacterium cellulosolvens, Eubacterium ramulus and Lachnospiraceae CG191 (11,38). After the initial hydrolysis, the resultant monomers and the aglycones are metabolized via decarboxylation and ring-cleavage to form simpler forms such as hydroxyphenyl propionic acid and hydroxyphenyl acetic acids (39). Polyphenols can stimulate the growth of commensal and beneficial microbi- ota while inhibiting pathogenic bac- teria. Coffee, tea and red wine are all rich sources of polyphenols associated with prebiotic and bifidogenic activity. For example, the growth of Clostridium perfringens, C. difficile and Bacteroides spp. was significantly inhibited by tea phenolics and their derivatives, while Bifidobacterium spp. and Lactobacillus spp. were less affected (40). Moreover, reductions in pathogenic C. perfringens and C. histolyticum spp. have been ob- served after consumption of fruit, seed, wine and tea polyphenols (40-44). Next, the study of Queipo-Ortuno et al. (45) showed that daily consumption of red wine polyphenols increased abundance of Bifidobacterium spp., Prevotella spp., Bacteroides spp., Enterococcus spp., Bacteroides uniformis, and Blautia coc- coides-Eubacterium rectale. 7 Different diets There are many popular diets includ- ing Western, gluten-free, vegan or vege- tarian, Mediterranean, etc. Most of these diets due to different composition affect selective growth of different bacteria in the gut and have been linked to different microbiome profiles. For instance, West- ern diet can cause dysbiosis by increas- ing the counts of Clostridium innocuum, Eubacterium dolichum, Catenibacterium mitsuokai and Enterococcus spp. and at the same time decreasing Bifidobacteria spp., Eubacteria spp. and Bacteroidetes spp. (11). Wu et al. (46) showed that the Bacte- roides enterotype were highly associated with a diet rich in animal protein, partic- ular types of amino acids and saturated fats (as in Western diet) (Figure 3). On the contrary, the Prevotella enterotype Figure 3: Impact of different diets on gut microbiota (According to Singh et al., 2017) (22). 187 PROFESSIONAL ARTICLE The influence of dietary compounds on gut microbiota was associated with high intake of car- bohydrates and simple sugars (46,47). Furthermore, SCFAs are found in low- er amounts in individuals consuming a Western diet due to lower intake of dietary fibre. Consumption of Western diet has also been linked to production of cancer-promoting nitrosamines (5). Scott et al. demonstrated that aerobic genera, such as Escherichia, Pseudomo- nas, Proteus, and Klebsiella, were able to produce nitrosamines (48). A gluten free diet (GFD) is a diet used for the treatment of celiac disease. However, it has also become very pop- ular among healthy individuals. It has been shown that a GFD could lead to modifications of the composition of gut microbiota and consequently immune properties (4). In studies of the intestinal microbiota in humans with celiac dis- ease, the counts of aerobic Staphylococ- cus spp., as well as anaerobic Clostridium and Bacteroides spp., were higher when compared with healthy adults. Further- more, the gut microbiota of individuals adhering to GFD is characterized by low Bifidobacterium spp. and Lactoba- cillus spp., whereas potentially patho- genic bacteria, such as E. coli and total Enterobacteriaceae family, increased proportionally with the reduction in polysaccharide/fibres intake after the in- troduction of GFD (5,11). Even a short- term GFD leads to reduced levels of Ru- minococcus bromii and Roseburia faecis and increased Victivallaceae and Clostri- diaceae spp. (5,11). It is therfore import- ant to include prebiotic-rich foods in the GFD diet, such as fructan type resistant starches (i.e. oligofructose and inulin), to avoid adverse effects of GFD on the gut microbiota and to promote the growth of beneficial species in the GIT (11). Vegan and vegetarian diets are rich in fermentable plant-based foods. The high amounts of fibre consumed can modu- late the composition of gut microbio- ta, and those individuals that adhere to vegan or vegetarian diet were reported to have a microbiota characterized by a lower abundance of Bacteroides spp. and Bifidobacterium spp. (5). High amounts of fibre intake can result in increased SCFA production, which can decrease intestinal pH. Individuals consuming a vegan or vegetarian diet showed lower intestinal and stool pH, which prevent- ed the growth of potentially pathogenic bacteria such as E. coli and other mem- bers of the Enterobacteriaceae family (47). Also, enrichment of genus Prevotel- la versus Bacteroides was shown for veg- etarians and individuals who consume a high proportion of fruit and vegetables and a low proportion of meat (11). The Mediterranean diet is often re- garded as a healthy balanced diet. It is characterized by high intake of vegeta- bles, moderate consumption of poultry, olive oil, cereals, legumes, wine, nuts, fish and a low amount of red meat, dairy products, and refined sugars. It is bene- ficial due to higher content of mono-un- saturated and poly-unsaturated fatty ac- ids, as well as high levels of antioxidants, fibres and vegetable protein content (5). The gut microbiota in individuals con- suming Mediterranean diet showed in- creased levels of Lactobacillus spp., Bi- fidobacterium spp., and Prevotella spp., and low levels of Clostridium spp. (5,11). The positive effect of Mediterranean diet is associated with weight loss, improve- ment of the lipid profile and decreased inflammation, which might be the result of diet-derived changes in the composi- tion of gut microbiota (5). The dietary protein intake in humans differs greatly according to the food availability and cultural dietary habits (46). While the daily protein intake in 188 GASTRO-ENTEROLOGY Zdrav Vestn | March – April 2021 | Volume 90 | https://doi.org/10.6016/ZdravVestn.3005 developing countries presents a per- sistent problem, the avarage protein in- take in developed countries is usually higher than the recommended dietary intake of 0.83 g of protein/kg/day (49). High protein diets are mainly character- ized by a higher proportion of protein (25 – 30% of total energy intake) when compared to the usual macronutrient proportion (24). Such diets with caloric restriction may facilitate body weight re- duction while increasing satiety but are also associated with potentially deleteri- ous health effects in the long-term (23). The ratio of available carbohydrates to protein determines substrate utilization by the gut microbiota, and the availabil- ity of complex carbohydrates generally lowers protein fermentation (23). In individuals consuming a high-pro- tein diet counts of Bifidobacterium spp. and the butyrate producing bacteria Roseburia/Eubacterium rectale were re- duced (23,24). The ingestion of resistant starch has been positively associated with both Bifidobacterium and Eubacterium spp., and reduced intake of carbohydrates led do a decline of both genera (24). 8 Prebiotics and probiotics Prebiotics are foods or dietary sup- plements that encourage the growth of saccharolytic bacteria that metabolize non-digestible carbohydrates such as in- ulin and fructose-rich oligosaccharides (FOS). In order to be considered a pre- biotic, the product must be resistant to gastric acidity, non-digestible by the host in the small intestine, fermentable by bacteria, and promote the abundance of beneficial bacteria (49). Mechanisms be- hind the beneficial effects of dietary fibre include SCFA production, stimulation of intestinal gluconeogenesis, increased epithelial integrity, release of peptide YY (PYY) and of glucagon-like neuropep- tide-1 (GLP-1) to promote satiety and insulin sensitivity, increased expression of antimicrobial peptides, and alteration of gut microbiota composition (35). In- clusion of 10% (w/w) short chain FOS in high-fat diets (60% kcal from fat) altered gut microbiota composition and func- tion as measured by changes in meta- bolic by-products of the gut microbiota (50). Also, inclusion of fibres improved insulin sensitivity in humans (50). Con- sumption of galacto- oligosaccharides (GOS) and FOS has shown to improve gut microbiota composition by increas- ing bifidobacteria and decreasing E. coli (50). Nowadays, probiotics are high- ly investigated for their effects on host health. They also represent one of the most widely consumed dietary supple- ments (10). Lactic acid bacteria can be found in fermented food such as yogurt and represent microorganisms that may beneficially regulate intestinal health through their effect on the gut microbi- ota composition and production of an- ti-inflammatory cytokine IL-10 (5). Probiotics are thought to have an- ti-inflammatory, hypoglycaemic, insuli- notropic, antioxidative, and satietogenic properties (10). However, studies inves- tigating the effects of probiotics on the human gut microbiota have inconclusive results which might be a consequence of variations in individual responses to probiotics and probiotic colonization (51-55). A clinical study of Ferrario et al. that included healthy adults who were given the probiotic strain L. paracasei DG re- vealed that the changes observed in the gut microbiota composition depend- ed on an individual’s starting microbial profile (53). 189 PROFESSIONAL ARTICLE The influence of dietary compounds on gut microbiota Mixed strain probiotics or synbiot- ics (combination of prebiotics and pro- biotics) seem to be more efficient than single microbial isolate alone (35). A randomized placebo-controlled trial of Rajkumar et al. included 60 overweight healthy adults who were given probiot- ic mixture containing three strains of Bifidobacterium, four strains of Lacto- bacillus, and one strain of Streptococcus (VSL #3) genera. Significant increases in the concentration of Lactobacillus spp., Bifidobacteria spp., and Strepto- coccus spp. were found when compared to placebo (56). The adults from the study also had fewer total coliforms and E. coli, as well as reduced triglycerides, total cholesterol, LDL-cholesterol, VLDL-cholesterol, and high-sensitiv- ity C-reactive protein. Probiotic-con- taining yogurt has also been shown to significantly reduce counts of the en- teropathogens E. coli and Helicobacter pylori (57). Even though probiotics present a promising therapy, more evidence is needed. The assessment of probiot- ic colonization ability, including their load in the lumen or mucosa, position throughout the GIT and how long they remain in GIT after supplementation ceases needs further research. Also, the efficacy of probiotics in the modulation of gut microbiota composition needs further investigation, given the great inter- individual variation in microbi- ota composition (10,35). 9 Conclusion The gut microbiota is a complex eco- system that undergoes variations and adapts to its host over lifetime due to many factors. Increasingly recognized is the influence of diet on gut microbiota composition. Digestible and non-digest- ible carbohydrates, protein, fats, poly- phenols, pre-and probiotics, as well as different dietary regimes all induce shifts in the gut microbiota with consequent modulation of the host immunologic and metabolic markers. Gut microbiota has been associated with the occurrence of diseases such as chronic gastrointes- tinal diseases, obesity, autism, diabetes, chronic inflammation, etc. Considering this close relationship between the diet, gut microbiota and health, it might be possible to improve our health through diet modulation. Changing the gut mi- crobiota through diet, probiotics, pre- biotics, and even antibiotics might offer a powerful route to preventing many of ‘Western-associated’ diseases. Long-term dietary habits have the most profound impact on the gut mi- crobiota. For that reason, healthy eating patterns with adequate intake of fruits and vegetables, ensuring a rich source of dietary fibre, together with healthy fats (mono- and poly-unsaturated fatty ac- ids) and a trend towards more plant-de- rived proteins could help promote gut microbiota diversity and functionality enabling it to benefit its host. References 1. Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med. 2019;216(1):20-40. DOI: 10.1084/jem.20180448 PMID: 30322864 2. Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67(9):1716-25. DOI: 10.1136/ gutjnl-2018-316723 PMID: 29934437 3. Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GA, Gasbarrini A, et al. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019;7(1):14. DOI: 10.3390/microorganisms7010014 PMID: 30634578 190 GASTRO-ENTEROLOGY Zdrav Vestn | March – April 2021 | Volume 90 | https://doi.org/10.6016/ZdravVestn.3005 4. Mills S, Stanton C, Lane JA, Smith GJ, Ross RP. Precision Nutrition and the Microbiome, Part I: Current State of the Science. Nutrients. 2019;11(4):923. DOI: 10.3390/nu11040923 PMID: 31022973 5. Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15(1):73. DOI: 10.1186/s12967-017-1175-y PMID: 28388917 6. Lazar V, Ditu LM, Pircalabioru GG, Picu A, Petcu L, Cucu N, et al. Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity. Front Nutr. 2019;6:21. DOI: 10.3389/fnut.2019.00021 PMID: 30931309 7. Costea PI, Hildebrand F, Arumugam M, Bäckhed F, Blaser MJ, Bushman FD, et al. Enterotypes in the landscape of gut microbial community composition. Nat Microbiol. 2018;3(1):8-16. DOI: 10.1038/s41564- 017-0072-8 PMID: 29255284 8. Zhao J, Zhang X, Liu H, Brown MA, Qiao S. Dietary Protein and Gut Microbiota Composition and Function. Curr Protein Pept Sci. 2019;20(2):145-54. DOI: 10.2174/1389203719666180514145437 PMID: 29756574 9. Diether NE, Willing BP. Microbial Fermentation of Dietary Protein: An Important Factor in Diet⁻Microbe⁻ Host Interaction. Microorganisms. 2019;7(1):19. DOI: 10.3390/microorganisms/7010019 PMID: 30642098 10. Kolodziejczyk AA, Zheng D, Elinav E. Diet-microbiota interactions and personalized nutrition. Nat Rev Microbiol. 2019;17(12):742-53. DOI: 10.1038/s41579-019-0256-8 PMID: 31541197 11. Duda-Chodak A, Tarko T, Satora P, Sroka P. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. Eur J Nutr. 2015;54(3):325-41. DOI: 10.1007/s00394-015-0852-y PMID: 25672526 12. Takiishi T, Fenero CI, Câmara NO. Intestinal barrier and gut microbiota: shaping our immune responses throughout life. Tissue Barriers. 2017;5(4):e1373208. DOI: 10.1080/21688370.2017.1373208 PMID: 28956703 13. Henderickx JG, Zwittink RD, van Lingen RA, Knol J, Belzer C. The Preterm Gut Microbiota: An Inconspicuous Challenge in Nutritional Neonatal Care. Front Cell Infect Microbiol. 2019;9:85. DOI: 10.3389/ fcimb.2019.00085 PMID: 31001489 14. Tauchi H, Yahagi K, Yamauchi T, Hara T, Yamaoka R, Tsukuda N, et al. Gut microbiota development of preterm infants hospitalised in intensive care units. Benef Microbes. 2019;10(6):641-51. DOI: 10.3920/ BM2019.0003 PMID: 31179713 15. Catinean A, Neag MA, Mitre AO, Bocsan CI, Buzoianu AD. Microbiota and Immune-Mediated Skin Diseases- An Overview. Microorganisms. 2019;7(9):E279. DOI: 10.3390/microorganisms7090279 PMID: 31438634 16. Iizumi T, Battaglia T, Ruiz V, Perez Perez GI. Gut microbiome and antibiotics. Arch Med Res. 2017;48(8):727- 34. DOI: 10.1016/j.arcmed.2017.11.004 PMID: 29221800 17. Madsen L, Myrmel LS, Fjære E, Liaset B, Kristiansen K. Links between Dietary Protein Sources, the Gut Microbiota, and Obesity. Front Physiol. 2017;8:1047. DOI: 10.3389/fphys.2017.01047 PMID: 29311977 18. Martin AM, Sun EW, Rogers GB, Keating DJ. The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release. Front Physiol. 2019;10:428. DOI: 10.3389/ fphys.2019.00428 PMID: 31057420 19. Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56-64. DOI: 10.1038/nature18846 PMID: 27383980 20. Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients. 2019;11(7):1613. DOI: 10.3390/nu11071613 PMID: 31315227 21. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514(7521):181-6. DOI: 10.1038/ nature13793 PMID: 25231862 22. Lang JM, Pan C, Cantor RM, Tang WH, Garcia-Garcia JC, Kurtz I, et al. Impact of Individual Traits, Saturated Fat, and Protein Source on the Gut Microbiome. MBio. 2018;9(6):e01604-18. DOI: 10.1128/mBio.01604-18 PMID: 30538180 23. Portune KJ, Beaumont M, Davila A-M, Tom D, Blachier F, Sanz Y. Gut microbiota role in dietary protein metabolism and health-related outcomes: The two sides of the coin. Trends Food Sci Technol. 2016;57 Part B:213-32. DOI: 10.1016/j.tifs.2016.08.011 24. Blachier F, Beaumont M, Portune KJ, Steuer N, Lan A, Audebert M, et al. High-protein diets for weight management: interactions with the intestinal microbiota and consequences for gut health. A position paper by the my new gut study group. Clin Nutr. 2019;38(3):1012-22. DOI: 10.1016/j.clnu.2018.09.016 PMID: 30274898 25. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105(43):16731-6. DOI: 10.1073/pnas.0804812105 PMID: 18936492 26. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661-72. DOI: 10.1038/nrmicro3344 PMID: 25198138 191 PROFESSIONAL ARTICLE The influence of dietary compounds on gut microbiota 27. Lecomte V, Kaakoush NO, Maloney CA, Raipuria M, Huinao KD, Mitchell HM, et al. Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS One. 2015;10(5):e0126931. DOI: 10.1371/journal.pone.0126931 PMID: 25992554 28. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. 2014;505(7484):559,63. DOI: 10.1038/nature12820 PMID: 24336217 29. Wan Y, Wang F, Yuan J, Li J, Jiang D, Zhang J, et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled- feeding trial. Gut. 2019;68(8):1417-29. DOI: 10.1136/gutjnl-2018-317609 PMID: 30782617 30. Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at- risk’ population. Int J Obes. 2013;37(2):216-23. DOI: 10.1038/ijo.2012.33 PMID: 22410962 31. Drasar BS, Crowther JS, Goddard P, Hawksworth G, Hill MJ, Peach S, et al. The relation between diet and the gut microflora in man. Proc Nutr Soc. 1973;32(2):49-52. DOI: 10.1079/PNS19730014 PMID: 4791056 32. Urwin HJ, Miles EA, Noakes PS, Kremmyda LS, Vlachava M, Diaper ND, et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. Br J Nutr. 2014;111(5):773-84. DOI: 10.1017/S0007114513003097 PMID: 24128654 33. Martinez KB, Leone V, Chang EB. Western diets, gut dysbiosis, and metabolic diseases: are they linked? Gut Microbes. 2017;8(2):130-42. DOI: 10.1080/19490976.2016.1270811 PMID: 28059614 34. Huang EY, Leone VA, Devkota S, Wang Y, Brady MJ, Chang EB. Composition of dietary fat source shapes gut microbiota architecture and alters host inflammatory mediators in mouse adipose tissue. JPEN J Parenter Enteral Nutr. 2013;37(6):746-54. DOI: 10.1177/0148607113486931 PMID: 23639897 35. Prieto I, Hidalgo M, Segarra AB, Martínez-Rodríguez AM, Cobo A, Ramírez M, et al. Influence of a diet enriched with virgin olive oil or butter on mouse gut microbiota and its correlation to physiological and biochemical parameters related to metabolic syndrome. PLoS One. 2018;13(1):e0190368. DOI: 10.1371/ journal.pone.0190368 PMID: 29293629 36. Costantini L, Molinari R, Farinon B, Merendino N. Impact of Omega-3 Fatty Acids on the Gut Microbiota. Int J Mol Sci. 2017;18(12):2645. DOI: 10.3390/ijms18122645 PMID: 29215589 37. Del Bo’ C, Bernardi S, Marino M, Porrini M, Tucci M, Guglielmetti S, et al. Systematic Review on Polyphenol Intake and Health Outcomes: Is there Sufficient Evidence to Define a Health-Promoting Polyphenol-Rich Dietary Pattern? Nutrients. 2019;11(6):1355. DOI: 10.3390/nu11061355 PMID: 31208133 38. Braune A, Blaut M. Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes. 2016;7(3):216-34. DOI: 10.1080/19490976.2016.1158395 PMID: 26963713 39. Yadav M, Verma MK, Chauhan NS. A review of metabolic potential of human gut microbiome in human nutrition. Arch Microbiol. 2018;200(2):203-17. DOI: 10.1007/s00203-017-1459-x PMID: 29188341 40. Lee HC, Jenner AM, Low CS, Lee YK. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol. 2006;157(9):876-84. DOI: 10.1016/j.resmic.2006.07.004 PMID: 16962743 41. Cuervo A, Valdés L, Salazar N, de los Reyes-Gavilán CG, Ruas-Madiedo P, Gueimonde M, et al. Pilot study of diet and microbiota: interactive associations of fibers and polyphenols with human intestinal bacteria. J Agric Food Chem. 2014;62(23):5330-6. DOI: 10.1021/jf501546a PMID: 24877654 42. Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, Spencer JP. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr. 2011;93(1):62-72. DOI: 10.3945/ajcn.110.000075 PMID: 21068351 43. Cueva C, Sánchez-Patán F, Monagas M, Walton GE, Gibson GR, Martín-Álvarez PJ, et al. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: changes in microbial groups and phenolic metabolites. FEMS Microbiol Ecol. 2013;83(3):792-805. DOI: 10.1111/1574-6941.12037 PMID: 23121387 44. Sánchez-Patán F, Cueva C, Monagas M, Walton GE, Gibson GR, Quintanilla-López JE, et al. In vitro fermentation of a red wine extract by human gut microbiota: changes in microbial groups and formation of phenolic metabolites. J Agric Food Chem. 2012;60(9):2136-47. DOI: 10.1021/jf2040115 PMID: 22313337 45. Queipo-Ortuño MI, Boto-Ordóñez M, Murri M, Gomez-Zumaquero JM, Clemente-Postigo M, Estruch R, et al. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr. 2012;95(6):1323-34. DOI: 10.3945/ajcn.111.027847 PMID: 22552027 46. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105-8. DOI: 10.1126/science.1208344 PMID: 21885731 47. Zimmer J, Lange B, Frick JS, Sauer H, Zimmermann K, Schwiertz A, et al. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr. 2012;66(1):53-60. DOI: 10.1038/ ejcn.2011.141 PMID: 21811294 48. Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH. The influence of diet on the gut microbiota. Pharmacol Res. 2013;69(1):52-60. DOI: 10.1016/j.phrs.2012.10.020 PMID: 23147033 192 GASTRO-ENTEROLOGY Zdrav Vestn | March – April 2021 | Volume 90 | https://doi.org/10.6016/ZdravVestn.3005 49. Zaman SA, Sarbini SR. The potential of resistant starch as a prebiotic. Crit Rev Biotechnol. 2016;36:578-84. DOI: 10.3109/07388551.2014.993590 PMID: 25582732 50. Respondek F, Gerard P, Bossis M, Boschat L, Bruneau A, Rabot S, et al. Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice. PLoS One. 2013;8(8):e71026. DOI: 10.1371/journal.pone.0071026 PMID: 23951074 51. Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol. 2014;87(2):357-67. DOI: 10.1111/1574-6941.12228 PMID: 24117923 52. Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9):9. DOI: 10.3390/nu9091021 PMID: 28914794 53. Ferrario C, Taverniti V, Milani C, Fiore W, Laureati M, De Noni I, et al. Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. J Nutr. 2014;144(11):1787-96. DOI: 10.3945/jn.114.197723 PMID: 25332478 54. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016;8(1):52. DOI: 10.1186/s13073-016-0300-5 PMID: 27159972 55. Laursen MF, Laursen RP, Larnkjær A, Michaelsen KF, Bahl MI, Licht TR. Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. BMC Microbiol. 2017;17(1):175. DOI: 10.1186/s12866-017-1090-7 PMID: 28818050 56. Rajkumar H, Mahmood N, Kumar M, Varikuti SR, Challa HR, Myakala SP. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial. Mediators Inflamm. 2014;2014:348959. DOI: 10.1155/2014/348959 PMID: 24795503 57. Yang YJ, Sheu BS. Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children. Helicobacter. 2012;17(4):297-304. DOI: 10.1111/j.1523-5378.2012.00941.x PMID: 22759330